Ponlimsi Q Code: Q5173
Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg
Drug & Product Overview
About Ponlimsi
Ponlimsi is a medication aligned to the HCPCS Q Code: Q5173 for billing, pricing, and reimbursement purposes in the United States. It is an Osteoporosis drug.
Manufacturers, reach out to us to add more information.
NDC Code Information
No NDC packages are aligned to Q5173 in publicly available CMS files.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| No public NDC alignments | ||||
Denosumab Biosimilar Information:
Ponlimsi Approval Date: March 27, 2026
| Product Name | HCPCS Code | Active Ingredient | BLA Type |
|---|---|---|---|
| Prolia | J0897 | Denosumab | 351(a) Originator Product |
| Jubbonti and Wyost | Q5136 | Denosumab | 351(k) Interchangeable |
| Ospomyv and Xbryk | Q5159 | Denosumab | 351(k) Interchangeable |
| Stoboclo and Osenvelt | Q5157 | Denosumab | 351(k) Interchangeable |
| Bomyntra and Conexxence | Q5158 | Denosumab | 351(k) Interchangeable |
| Bildyos and Bilprevda | Q5162 | Denosumab | 351(k) Interchangeable |
| Aukelso and Bosaya | Q5161 | Denosumab | 351(k) Interchangeable |
| Enoby and Xtrenbo | Q5167 | Denosumab | 351(k) Interchangeable |
| Osvyrti and Jubereq | Q5166 | Denosumab | 351(k) Interchangeable |
| Oziltus | Q5165 | Denosumab | 351(k) Interchangeable |
| Boncresa | Q5171 | Denosumab | 351(k) Interchangeable |
| Ponlimsi | Q5173 | Denosumab | 351(k) Interchangeable |
Ponlimsi CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Ponlimsi billing and coding guide?
Are there any available Ponlimsi patient assistance programs?
Where can I find Ponlimsi prescribing information?
Where can I find Ponlimsi side effect information?
Does billing Ponlimsi require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Ponlimsi.
